Current drug delivery2026ResearchDrug Delivery
1. Doxorubicin Nanocarriers in Glioblastoma Therapy: Advances and Limitations
Colpan Rd
Glioblastoma (GBM) remains one of the most aggressive brain malignancies, with limited therapeutic success largely due to the restrictive nature of the Blood-Brain Barrier (BBB) and intrinsic drug resistance mechanisms. Despite standard treatment strategies, the median survival remains approximately 16 months…
Read the article